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Progress and open challenges in extremely high-dimensional
medical outcome prediction
par Kevin Bleakley
Using biological data for medical decisions requires ”extremely high” pre-
diction accuracy ; mistakes can lead to death. Very few current statistical
methods are good enough to be used in life-threatening clinical decisions,
e.g. choice of low vs high chemotherapy dose for breast cancer patients. Dif-
ficulties include (1) the above moral reason, (2) high-dimensionality of data
(p >> n) and (3) the possibility that data does not contain enough informa-
tion to construct a near-perfect classification rule. I will review the current
state-of-the-art in high-dimensional biological decision-making, showing what
statistical methods are being used, their success (or lack of), and suggest pos-
sible future research directions. In particular, I will describe Next Generation
Sequencing approaches, their faster-than-exponential drop in cost, and im-
plications for the next five years at the statistics/biology interface.
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